Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Sulzer Ltd
  6. News
  7. Summary
    SUN   CH0038388911

SULZER LTD

(SUN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sulzer : Record profitability and cash flow on continuing sales momentum

07/22/2021 | 12:08am EDT

Continuing commercial momentum, positive mix effect

Orders grew again (8% sequentially) in Q2 2021, delivering an H1 order intake of CHF 1'820.4 million, flat (0.2% increase) year-on-year despite a high comparable base in 2020. Acquisitions contributed CHF 67.4 million and currency translation effects had a negative impact of CHF 24.0 million. Order intake gross margin increased to 35.3%, well up from 33.3% in H1 2020 on a better mix.

In Pumps Equipment, order growth in Water and Industry only partially offset the programmed drop in Energy, leading to a decrease of 15.3% (-20.2% organically) for the division. Water orders increased by 25.2%, 7.0% of which was organic and CHF 39.4 million from the Nordic Water acquisition. Industry also had a strong H1 2021, with orders up 5.8%. Energy declined by half versus a very strong H1 2020, on a market correction for which we have already adjusted our cost base, and on continued order selectivity to defend the quality of our backlog.

In Q2 2021, Rotating Equipment Services recorded its highest quarterly order intake since Q1 2020, emphasizing the positive sequential momentum in all regions as customers begin to ease site access restrictions. Compared to the record high H1 2020, the division order intake declined 5.6% in H1 2021.

Chemtech's order intake increased by 12.8% in H1 2021, driven by a strengthening US chemical market and a continuing boom in China. Our Renewables segment also showed solid growth, with H1 orders approaching the level achieved for the full year 2020.

In the Applicator Systems division, orders reached a record level of CHF 268.9 million thanks to strong customer demand coupled with our ability to keep our supply chain up and running. The Haselmeier acquisition contributed CHF 25.5 million. Orders in H1 2021 increased by 69.4% (+53.3% organically) versus H1 2020 and are well above pre-pandemic levels.

We enter the second half of 2021 with a high order backlog of CHF 1'948.9 million (December 31, 2020: CHF 1'758.9 million). Positive currency translation effects totaled CHF 31.1 million.

Sales ramp up in all divisions

Sales increased by 9.2% compared to H1 2020, reaching CHF 1'723.3 million. Organic growth was 6.1% with acquisitions adding CHF 52.1 million, while negative currency translation effects amounted to CHF 22.3 million.

The Pumps Equipment division increased its sales by 8.8% (4.4% organically). Sales in Water increased by 23.7% including the successful Nordic Water acquisition, and 9.3% organically. Sales in Industry increased 12.6%. Overall, Water and Industry more than offset the sales decline in Energy (-4.7%), leading to a positive mix effect. Sales in Rotating Equipment Services were up 1.3% year-on-year, growing in all regions, in part due to the continued easing of customer site restrictions. In Chemtech, sales were up by 7.7% on strong execution in China and a reduced impact from lockdowns compared to last year, particularly for field services. Sales in Applicator Systems rebounded strongly with 38.4% growth in H1 2021 compared to H1 2020. The Haselmeier acquisition contributed CHF 21.3 million. Healthcare now represents 38.5% of Applicator Systems sales.

Operational profitability at 10%, a half-year record

Operational profit amounted to CHF 171.6 million, compared with CHF 120.2 million in the first half of 2020, an increase of 43.5%. The higher gross profit from increased sales and a better mix was further supported by CHF 23 million of savings from implemented resizing measures in the Energy-related businesses and continued spending discipline.

Operational profitability reached a record H1 high of 10.0%, compared with 7.5% in H1 2020.

Return on Sales of 7.5%

One-off expenses in the first half of 2021 amounted to CHF 7.2 million, compared to CHF 52.6 million in H1 2020. The expenses relate to the structural actions to adapt Sulzer's Energy-related activities, initiated in the first half of 2020. EBIT amounted to CHF 128.7 million, compared with CHF 36.0 million in the first half of 2020. Return on sales (ROS) was 7.5% compared with 2.3% in the same period of 2020.

Record free cash flow generation

Free cash flow amounted to CHF 117.1 million in H1 2021, significantly up compared to the CHF 36.8 million reported in the same period last year, driven by higher net income and improved working capital efficiency.

Proposed spin-off of Applicator Systems

On May 27, Sulzer announced its intention to spin-off its Applicator Systems (APS) division through a 1:1 share split, subject to shareholder approval at the Sulzer EGM to be scheduled for Q3. Upon market introduction, APS will be renamed medmix and Sulzer shareholders will receive one medmix share in addition to each Sulzer share held. medmix's listing on the Swiss Exchange (SIX) is planned for late Q3 or early Q4 and is expected to be combined with a concurrent share capital increase by medmix in the amount of CHF 200-300 million without subscription rights for existing shareholders, also subject to shareholder approval The spin-off will accelerate the profitable growth of both Sulzer and medmix.

Outlook 2021

The positive trend in order intake continued in Q2, with all divisions again seeing sequential growth. While Q3 is generally seasonally lower, we expect it to show a strong improvement compared to the previous year, driven by continued growth in Applicator Systems and Chemtech, along with a re-acceleration in Rotating Equipment Services and sustained growth in Water and Industry in Pumps Equipment.

We confirm the guidance that was increased on our Capital Markets Day in June. For the full year 2021, we expect orders to increase 4-6%1, sales to be up 8-10%1, and operational profitability between 10.0% and 10.5%.

Without medmix, Sulzer expects 2021 orders to be up 2-3%1 and sales up 6-8%1. Operational profitability is expected to be around 9.0%, above pre-pandemic levels.

Disclaimer

Sulzer AG published this content on 22 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 July 2021 04:07:10 UTC.


© Publicnow 2021
All news about SULZER LTD
09/07GLOBAL MARKETS LIVE : Ryanair, Hyundai, Adecco, Goldman Sachs, JD.com...
09/07SULZER : Morgan Stanley Lifts Price Target on Sulzer, Maintains Equalweight/Caut..
MT
09/06SULZER : to Spin Off, Float Applicator Systems Division
MT
08/31SULZER : Mixpac receives EcoVadis award
PU
08/18Sulzer Plans to List Applicator Systems Division
CI
08/17SULZER : Invitation to extraordinary general meeting of Sulzer Ltd to be held on..
PU
07/26SULZER : Research Partners Lifts Price Target on Sulzer, Maintains Buy Recommend..
MT
07/22SULZER : H1 Earnings Surge 455% Amid Sales Growth In All Divisions
MT
07/22SULZER : Midyear results 2021 presentation (pdf)
PU
07/22SULZER : Record profitability and cash flow on continuing sales momentum
PU
More news
Analyst Recommendations on SULZER LTD
More recommendations
Financials
Sales 2021 3 458 M 3 708 M 3 708 M
Net income 2021 161 M 173 M 173 M
Net Debt 2021 319 M 342 M 342 M
P/E ratio 2021 28,4x
Yield 2021 3,05%
Capitalization 4 510 M 4 845 M 4 836 M
EV / Sales 2021 1,40x
EV / Sales 2022 1,27x
Nbr of Employees 15 054
Free-Float 49,4%
Chart SULZER LTD
Duration : Period :
Sulzer Ltd Technical Analysis Chart | SUN | CH0038388911 | MarketScreener
Technical analysis trends SULZER LTD
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 133,30 CHF
Average target price 134,20 CHF
Spread / Average Target 0,68%
EPS Revisions
Managers and Directors
Grégoire Poux-Guillaume Chief Executive Officer
Jill Lee Chief Financial Officer
Peter D. Löscher Chairman
Gerhard Roiss Independent Non-Executive Director
Hanne Birgitte Sorensen Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SULZER LTD43.18%4 845
ATLAS COPCO AB41.11%79 216
FANUC CORPORATION5.01%46 484
TECHTRONIC INDUSTRIES COMPANY LIMITED44.85%37 757
PARKER-HANNIFIN CORPORATION6.29%37 133
SANDVIK AB5.37%30 638